Skip to main content
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Stephen Taub
Latest Articles
Premium
Sosin Partners Takes Profits on Carvana After Turning Crisis Into Windfall
Stephen Taub
September 24, 2025
Premium
RTW’s Wong: Biotech’s Five-Year Slump Is Over
Stephen Taub
September 23, 2025
Premium
Discovery’s Big Digital Asset Bet
Stephen Taub
September 22, 2025
Premium
Glenview Is Once Again Profitable
Stephen Taub
September 17, 2025
Premium
D1 Capital Leads Tiger Crowd as Hedge Fund Returns Diverge in August
Stephen Taub
September 15, 2025
Premium
Biopharma Hedge Funds Rebounded Sharply Last Month — But Is It Sustainable?
Stephen Taub
September 11, 2025
Premium
August Surge Offers Relief to Managed Futures Funds — But Not Redemption
Stephen Taub
September 10, 2025
Premium
Valiant’s Summer Slump
Stephen Taub
September 9, 2025
Premium
Third Point Falls Behind as August Loss Wipes Out the Year’s Gains
Stephen Taub
September 8, 2025
Premium
PointState Eyes StubHub IPO
Stephen Taub
September 4, 2025
Hedgies Prepare to Unload Stakes in a High-Profile SPAC
Stephen Taub
September 3, 2025
Premium
Einhorn’s Greenlight Misses the Rally, Again
Stephen Taub
September 2, 2025
Premium
In a Brutal Year for CTAs, One Fund Breaks Away
Stephen Taub
August 21, 2025
Premium
Chris Hansen’s Bet on Power Sparks Big Gains
Stephen Taub
August 20, 2025
Druckenmiller’s Equity Bets Hit Seven-Year Peak
Stephen Taub
August 18, 2025
Premium
Prominent Funds Bought the Nvidia Dip — Now It’s Paying Off
Stephen Taub
August 18, 2025
Premium
Biopharma Funds Deliver Rare Monthly Gains
Stephen Taub
August 14, 2025
Jeffrey Talpins’s Element Slashes U.S. Stock Holdings by 90% in Renewed Bearish Turn
Stephen Taub
August 13, 2025
More Articles